Fidelity Investments’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.8K Sell
9,401
-720
-7% -$3.18K ﹤0.01% 4416
2026
Q1
$36.5K Buy
10,121
+8,143
+412% +$28.2K ﹤0.01% 4257
2025
Q4
$6.75K Sell
1,978
-17,727
-90% -$86K ﹤0.01% 4828
2025
Q3
$134K Buy
19,705
+945
+5% +$7.8K ﹤0.01% 3543
2025
Q2
$256K Buy
18,760
+15,563
+487% +$147K ﹤0.01% 3220
2025
Q1
$17.4K Buy
3,197
+922
+41% +$5.23K ﹤0.01% 4279
2024
Q4
$11.3K Buy
2,275
+893
+65% +$4.68K ﹤0.01% 4430
2024
Q3
$7.24K Buy
1,382
+1,182
+591% +$6.82K ﹤0.01% 4527
2024
Q2
$1.37K Sell
200
-71
-26% -$650 ﹤0.01% 4768
2024
Q1
$2.78K Hold
271
﹤0.01% 4639
2023
Q4
$2.24K Hold
271
﹤0.01% 4622
2023
Q3
$1.69K Hold
271
﹤0.01% 4577
2023
Q2
$1.18K Hold
271
﹤0.01% 4685
2023
Q1
$460 Buy
+271
New +$479 ﹤0.01% 4808

Other funds holding LFMD

Fidelity Investments's LFMD Position: Q2 2026 in Review

Fidelity Investments reduced its LifeMD (LFMD) stake by 7.1% in Q2 2026, selling an estimated $3.18K and leaving 9,401 shares worth $38.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4416.

Fidelity Investments first reported a position in LFMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $256K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Fidelity Investments held 9,401 shares of LifeMD worth $38.8K as of Q2 2026.
  • Fidelity Investments sold 720 LifeMD shares in Q2 2026, an estimated $3.18K.
  • LifeMD made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4416 holding.
  • Fidelity Investments first reported a position in LifeMD in Q1 2023 and has held it in 14 quarters since.
  • Fidelity Investments's LifeMD position peaked at $256K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.